-PTI Bankura: West Bengal Chief Minister Mamata Banerjee on Saturday asked why the UPA government was in a hurry to legislate the Food Security Bill when its continuance was in doubt, while denying that Trinamool Congress was opposed to it. "Congress is saying that they are going to pass the National Food Security Bill and the Trinamool Congress is obstructing it," Ms. Banerjee told a panchayat election meeting here in Bankura district. "You...
More »SEARCH RESULT
Question of survival -TK Rajalakshmi
-Frontline Despite the negative observations and criticisms, there is a strong case for MGNREGS works to be continued even in States with high per capita incomes. Hisar and Fatehabad: CONTRARY to general opinion, demand for work under the Mahatma Gandhi National Rural Employment Guarantee Scheme (MGNREGS) is high in Haryana. Contrary also to the views in recent discussion papers, one of them commissioned by the Commission for Agricultural Cost and Prices...
More »Address the divergence
-The Hindu The rationale behind the Union government's decision to extend for four more years the Integrated Action Plan for naxal-affected districts in Andhra Pradesh, Bihar, Chhattisgarh, Jharkhand, Madhya Pradesh, Maharashtra, Odisha, Uttar Pradesh and West Bengal, is clear enough. So is its timing, coming as it does days after the Maoist rampage in Chhattisgarh. Out of an annual allocation of Rs. 1,000 crore, each of the 82 districts identified...
More »Indian pharma's generic challenge-DG Shah
-The Business Standard USFDA's zero tolerance policy requires our drug firms to reorient not just processes but organisational cultures to serve that market credibly The following two quotes from the United States Food and Drug Administration (FDA) news releases may help put the Ranbaxy controversy in perspective. The first sums up what it is that drives the FDA and the second is typical of the challenge the pharmaceutical industry faces. (1) "The consent...
More »Drugs, Ranbaxy and lies
-The Hindu Seven years after the first warning in June 2006 from the U.S. Food and Drug Administration (FDA) and five years after the Department of Justice initiated legal proceedings against the company, Ranbaxy is back in the news for the same wrong reasons. Last fortnight it pleaded guilty to felony charges in the U.S., admitting to selling adulterated drugs with intent to defraud, not reporting that its drugs failed...
More »